23andMe Holding Co.

NASDAQ: MEUSW · Real-Time Price · USD
1.38
-0.13 (-8.61%)
At close: Apr 24, 2025, 3:47 PM

Company Description

23andMe, Inc., a consumer genetics and research company, engages in developing a genetic database to unlock insights leading to the rapid discovery of new targets for drug development.

It offers a crowdsourced platform that helps people to access, understand, and benefit from the human genome; access direct-to-consumer genetic testing; and give consumers personalized information about their genetic health risks, ancestry, and traits.

The company was incorporated in 2006 and is based in Sunnyvale, California with an additional office in Mountain View, California.

23andMe Holding Co.
23andMe Holding Co. logo
Country United States
IPO Date Jun 17, 2021
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees n/a
CEO Anne Wojcicki

Contact Details

Address:
223 N. Mathilda Ave.
Sunnyvale, California
United States
Website http://www.23andme.com

Stock Details

Ticker Symbol MEUSW
Exchange NASDAQ
Fiscal Year n/a
Reporting Currency USD
CIK Code 0001804591
CUSIP Number
ISIN Number US90138Q3065
Employer ID 87-1240344
SIC Code 2834

Key Executives

No executives data available.

Latest SEC Filings

Date Type Title
Aug 15, 2025 8-K Current Report
Aug 04, 2025 10-Q Quarterly Report
Jul 25, 2025 10-K/A [Amend] Annual Report
Jul 14, 2025 8-K Current Report
Jun 30, 2025 8-K Current Report
Jun 20, 2025 SCHEDULE 13G Filing
Jun 16, 2025 SCHEDULE 13D/A [Amend] Filing
Jun 16, 2025 8-K Current Report
Jun 11, 2025 4 Filing
Jun 11, 2025 10-K Annual Report